The federal contract IDV award SPE2D222D0142 is a single award Indefinite Delivery Contract held by Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceutical and medical products. The contract has a ceiling value of $73,378,778.32 and a period of performance through April 6, 2027.
Under this IDV, Golden State Medical Supply provides a wide range of pharmaceutical products to federal agencies such as the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The products include medications for treating conditions like heartburn, diabetes, infections, and viral illnesses, including drugs like omeprazole, metformin, ciprofloxacin, levofloxacin, and valacyclovir. The company fulfills delivery orders against established price schedules or issues task orders for these standard medications and supplies through the VA and DoD Pharmaceutical Prime Vendor programs. This IDV was likely derived from a pre-solicitation issued by the Defense Logistics Agency for a firm-fixed price, requirements-type contract to establish a national supply source for Febuxostat tablets in 40mg and 80mg doses.
Generated 8/20/24, 9:09 AM